Scientists succeeded in reviving microbes retrieved from sediment deep under the seafloor in the heart of the South Pacific that had survived in a dormant state for 101.5 million years in research illustrating the resiliency of life on Earth.
Rebecca Vaught never set out to become an entrepreneur, but that’s exactly what happened when she launched Van Heron Labs during 2020 with a goal of reframing the understanding of the body’s organismal and cellular performance.
Atox Bio had positive results in the company’s Phase III ACCUTE trial for reltecimod for early treatment of severe Necrotizing Soft Tissue Infection (NSTI), a so-called flesh-eating disease.
Mutated COVID-19 Viral Strain in U.S. and Europe 10 Times More Contagious than Original StrainACE2 (angiotensin-converting enzyme-2), Asia, Cells, Coronavirus Disease 2019 (COVID-19), Europe, Genetic Mutations, Institutes, Mutations, Proteins, R&D, Researchers, Scripps Research Institute, Studies, United States
Researchers at the The Scripps Research Institute found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
A review of some recently published scientific studies includes one for antihistamines and similar compounds that might slow down Huntington’s disease.
Creative Agency Aims To Slow Coronavirus By Giving Away Plans For Barcode Scanner Fused With UV EmitterBacteria, Barcode Scanners, Coronavirus Disease 2019 (COVID-19), Healthcare Communications Agencies, Marketing & Advertising, Medical Devices, Packaging, Science Magazine, The New England Journal of Medicine (NEJM), UV-C Light Technology, Viruses
A new weapon in the war on coronavirus is on the way. Leading health creative agency The Bloc developed SafeCode, a unique device concept which fuses a barcode scanner with UV-C light technology proven to destroy dangerous viruses and bacteria, and is expected to do the same to SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19).
BioSpace Global Roundup: Jan. 30, 2020Alopecia, Anti-GBM Antibody Disease (Goodpasture´s Disease), Approvals, Bacteria, Business, Cancer, Clinical Trials, Deals, Diagnostics, Drug Discovery, European Commission, FDA/Regulatory, Hair Loss, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), New Indications, PD-1/PD-L1 inhibitors, Product Pipelines, R&D, Tumors
Pharma companies from across the globe provide updates on their pipelines and business.
Melinta Therapeutics filed for bankruptcy protection, becoming the latest casualty of a persistent cash burn in the antibiotic industry.
U.S. FDA Advisory Committee Recommends Approval of Cefiderocol for Treatment of Complicated Urinary Tract InfectionsAntibiotics, Antimicrobial Drugs Advisory Committee, Cephalosporins, Complicated Urinary Tract Infections (cUTI), FDA, FDA/Regulatory, Gram-negative bacteria, New Drug Application (NDA), Prescription Drug User-Fee Act (PDUFA), Pyelonephritis, Recommended For Approval
The U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee voted to recommend approval of Shionogi & Co. Ltd.’s investigational antibiotic cefiderocol for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, in patients with limited or no alternative treatment options.
Scientists have found multidrug-resistant “superbug” bacteria lurking on cash machines, escalators and handrails in London’s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.